Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors.

Literature DB >> 19755508

Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors.

Hilda Fragoso-Loyo, Javier Cabiedes, Yvonne Richaud-Patin, Alejandro Orozco-Narváez, Betty Diamond, Luis Llorente, Jorge Sánchez-Guerrero.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19755508 PMCID： PMC4516016 DOI： 10.1093/rheumatology/kep297

Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580

× No keyword cloud information.

7 in total

1. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus.

Authors: Hiroshi Okamoto; Yasuhiro Katsumata; Katsuji Nishimura; Naoyuki Kamatani
Journal: Arthritis Rheum Date: 2004-11

2. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

Authors: Czeslawa Kowal; Lorraine A Degiorgio; Ji Y Lee; Mark A Edgar; Patricio T Huerta; Bruce T Volpe; Betty Diamond
Journal: Proc Natl Acad Sci U S A Date: 2006-12-14 Impact factor: 11.205

Review 3. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

Authors:
Journal: Arthritis Rheum Date: 1999-04

4. Systemic lupus erythematosus disease activity index 2000.

Authors: Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal: J Rheumatol Date: 2002-02 Impact factor: 4.666

5. The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors: E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal: Arthritis Rheum Date: 1982-11

6. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.

Authors: H Fragoso-Loyo; Y Richaud-Patin; A Orozco-Narváez; L Dávila-Maldonado; Y Atisha-Fregoso; L Llorente; J Sánchez-Guerrero
Journal: Arthritis Rheum Date: 2007-04

7. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

Authors: Hilda Fragoso-Loyo; Javier Cabiedes; Alejandro Orozco-Narváez; Luis Dávila-Maldonado; Yemil Atisha-Fregoso; Betty Diamond; Luis Llorente; Jorge Sánchez-Guerrero
Journal: PLoS One Date: 2008-10-06 Impact factor: 3.240

7 in total

5 in total

Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors.

1. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus.

2. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

Review 3. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

4. Systemic lupus erythematosus disease activity index 2000.

5. The 1982 revised criteria for the classification of systemic lupus erythematosus.

6. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.

7. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.

Review 1. Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches.

2. Neurological Manifestations in Systemic Lupus Erythematosus: A Single Centre Study from North East India.

3. Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.

4. Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus.

Review 5. The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus.